Literature DB >> 25269875

[MALDI mass spectrometry of the meniscus. Objectification of morphological findings].

J Petzold1, R Casadonte, M Otto, M Kriegsmann, M Granrath, A Baltzer, J Vogel, P Drees, S Deininger, M Becker, J Kriegsmann.   

Abstract

BACKGROUND: The classification of meniscal lesions requires correlation with clinical data. For the standardization of histopathology reports a discrimination between normal, low-grade lesions and high-grade lesions is feasible. This classification can be further specified using other methods.
MATERIAL AND METHODS: Formalin-fixed, paraffin-embedded specimens of meniscal tissue from 68 patients were analyzed by matrix-assisted laser desorption ionization (MALDI) imaging.
RESULTS: The classification of meniscal lesions and differentiation between low-grade and high-grade and acute versus non-acute degeneration is possible by determination of the differential expression of mass-to-charge ratios by statistical comparisons using the P-value from combined Wilcoxon and Kruskal-Wallis (PWKW) tests and a predefined average two-fold difference in intensity.
CONCLUSION: The concept of a "meniscus report" is introduced for documentation of meniscus tissue specimens integrating histological, histochemical and proteomic data, thereby specifying the degree of degeneration and the assessment of acute or non-acute lesions. Mass spectrometry contributes to an objective histopathology report. An advisory opinion should always be based on close correlation of clinical and morphological evaluations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25269875     DOI: 10.1007/s00393-014-1468-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  25 in total

1.  Degeneration of the meniscus and progression of osteoarthritis.

Authors:  David Hunter
Journal:  HSS J       Date:  2011-12-28

2.  Osteoarthritis cartilage histopathology: grading and staging.

Authors:  K P H Pritzker; S Gay; S A Jimenez; K Ostergaard; J-P Pelletier; P A Revell; D Salter; W B van den Berg
Journal:  Osteoarthritis Cartilage       Date:  2005-10-19       Impact factor: 6.576

3.  MALDI MS imaging as a powerful tool for investigating synovial tissue.

Authors:  M Kriegsmann; E H Seeley; A Schwarting; J Kriegsmann; M Otto; H Thabe; B Dierkes; C Biehl; U Sack; A Wellmann; G J Kahaly; K Schwamborn; R M Caprioli
Journal:  Scand J Rheumatol       Date:  2012-05-29       Impact factor: 3.641

4.  Pathologic characteristics of the torn human meniscus.

Authors:  Mena Mesiha; David Zurakowski; Jamil Soriano; Jason H Nielson; Bertram Zarins; Martha M Murray
Journal:  Am J Sports Med       Date:  2006-11-07       Impact factor: 6.202

5.  Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Geraldine M McCarthy; Herman S Cheung
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

6.  The meniscus, calcification and osteoarthritis: a pathologic team.

Authors:  Paul A MacMullan; Geraldine M McCarthy
Journal:  Arthritis Res Ther       Date:  2010-05-20       Impact factor: 5.156

7.  Histology of the torn meniscus: a comparison of histologic differences in meniscal tissue between tears in anterior cruciate ligament-intact and anterior cruciate ligament-deficient knees.

Authors:  Keith Meister; Peter A Indelicato; Suzanne Spanier; John Franklin; Joel Batts
Journal:  Am J Sports Med       Date:  2004-09       Impact factor: 6.202

8.  Amyloid deposits in the knee joint at autopsy.

Authors:  C Ladefoged
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

9.  Localized amyloid in the menisci of the knee joint.

Authors:  H J Rumpelt; A Braun; R Spier; E G Suren; E Thies
Journal:  Pathol Res Pract       Date:  1996-06       Impact factor: 3.250

10.  [Calcinosis of the meniscus. Morphologic and roentgenographic findings for zonal classification].

Authors:  A Brandes; K M Müller
Journal:  Pathologe       Date:  1995-07       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.